Albuterol
In clinical developmentAlso known as Accuneb, Airet, Airsupra, Combivent+9 more
Accuneb, Airet, Airsupra, Combivent, DuoNeb, ProAir, ProAir HFA, Proventil, Salbutamol, Salbutamolum, Ventolin, Volmax, Albuterol Sulfate.
Recent clinical, regulatory, research and industry developments relating to this drug.
Ventilation and Perfusion in Individuals With Asthma
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Ventilation and Perfusion in Individuals With Asthma
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes1
Journals, researchers & institutions
- Chest1
- Lancet (London, England)1
- Pharmacotherapy1
- Pulmonary pharmacology & therapeutics1
- The Lancet. Respiratory medicine1
- Foxx-Lupo WT2
- Morgan WJ2
- Patanwala AE2
- Snyder EM2
- Wheatley CM2
- Bacharier LB1
- Bade E1
- Baronio R1
- University of Arizona2
- Arizona Respiratory Center1
- Center for Clinical Pediatric Pharmacology Research1
- College of Pharmacy1
- University of Ferrara1
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials